Clinical trial reportThe New England journal of medicinePublished
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
15 of 45 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The New England journal of medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Thalidomide; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Injections, Subcutaneous; Drug Resistance, Neoplasm; Time Factors; Adult
- PubMed ID
- 41363801
- PubMed Central ID
- PMC13218738
- Open access
- Yes, open
- Added to directory
- Source checked